Literature DB >> 1767544

Prognostic factors in primary gastrointestinal leiomyosarcoma: a retrospective study.

H Kimura1, Y Yonemura, N Kadoya, T Kosaka, K Miwa, I Miyazaki, T Sawa, S Yoshimitsu, Y Nishida, T Kamata.   

Abstract

Thirty-six patients who were admitted for surgical resection of leiomyosarcomas of the gastrointestinal tract to the Department of Surgery II, Kanazawa University Hospital, Kanazawa, Japan and its affiliates are included in the study. Follow-up data on survival is available for 32 patients. The clinico-pharmacologic variables, such as tumor site, tumor size, cellularity, mitotic index, and DNA ploidy pattern were analyzed and the results proved to correlate with the prognosis. Thirteen (41%) of the patients presented with distant metastases and/or recurrences, with hematogenous metastasis being the predominant type of recurrence. Local recurrences and/or distant metastases were significantly correlated with survival (p less than 0.001), as was tumor site (p less than 0.03), tumor size (p less than 0.04), surgical treatment (p = 0.05), and DNA ploidy pattern (p = 0.06). Neither the mitotic index nor the cellularity proved to be significantly correlated with survival. Furthermore, some of the patients with local recurrences or distant metastases survived long after resection of recurrent tumors. In view of the results, aggressive surgical resection may be an efficient treatment of recurrences.

Entities:  

Mesh:

Year:  1991        PMID: 1767544     DOI: 10.1007/bf01665316

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  14 in total

1.  Smooth muscle tumors of the stomach.

Authors:  D W Crocker
Journal:  Ann Surg       Date:  1969-08       Impact factor: 12.969

2.  A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations.

Authors:  F Gherlinzoni; G Bacci; P Picci; R Capanna; P Calderoni; E G Lorenzi; M Bernini; E Emiliani; E Barbieri; A Normand
Journal:  J Clin Oncol       Date:  1986-04       Impact factor: 44.544

3.  Primary colorectal sarcoma. A retrospective review and prognostic factor study of 50 consecutive patients.

Authors:  S Meijer; T Peretz; J J Gaynor; C Tan; S I Hajdu; M F Brennan
Journal:  Arch Surg       Date:  1990-09

4.  [A clinicopathological studies on gastrointestinal leiomyosarcomas, with special reference to prognosis].

Authors:  N Kadoya; Y Yonemura; S Oyama; T Kosaka; R Izumi; K Miwa; I Miyazaki
Journal:  Nihon Geka Gakkai Zasshi       Date:  1989-11

5.  Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.

Authors:  D W Hedley; C A Rugg; R D Gelber
Journal:  Cancer Res       Date:  1987-09-01       Impact factor: 12.701

6.  Results of multimodality therapy of resectable soft-tissue sarcomas of the retroperitoneum.

Authors:  J Glenn; W F Sindelar; T Kinsella; E Glatstein; J Tepper; J Costa; A Baker; P Sugarbaker; M F Brennan; C Seipp
Journal:  Surgery       Date:  1985-03       Impact factor: 3.982

7.  Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma).

Authors:  H D Appleman; E B Helwig
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

8.  Smooth muscle tumors of the gastrointestinal tract and retroperitoneum: a pathologic analysis of 100 cases.

Authors:  M Ranchod; R L Kempson
Journal:  Cancer       Date:  1977-01       Impact factor: 6.860

9.  Myosarcomas of the small and large intestine: a clinicopathologic study.

Authors:  M H Shiu; G H Farr; R A Egeli; S H Quan; S I Hajdu
Journal:  J Surg Oncol       Date:  1983-09       Impact factor: 3.454

10.  Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue.

Authors:  B Schutte; M M Reynders; F T Bosman; G H Blijham
Journal:  Cytometry       Date:  1985-01
View more
  8 in total

1.  Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.

Authors:  R P DeMatteo; J J Lewis; D Leung; S S Mudan; J M Woodruff; M F Brennan
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Surgical management of small gastrointestinal stromal tumors of the stomach.

Authors:  Makoto Iwahashi; Katsunari Takifuji; Toshiyasu Ojima; Masaki Nakamura; Mikihito Nakamori; Yoshihiro Nakatani; Kentaro Ueda; Koichiro Ishida; Teiji Naka; Kazuo Ono; Hiroki Yamaue
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

Review 3.  Primary leiomyosarcoma arising in the lesser sac: report of a case.

Authors:  H Kimura; K Maeda; K Konishi; A Tsuneda; K Tazawa; M Earashi; T Inoue; K Yabushita; Y Kuroda; M Tsuji; A Miwa
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  Analysis of prognostic and immunohistochemical factors in gastrointestinal stromal tumors with malignant potential.

Authors:  Halil Ozgüç; Tuncay Yilmazlar; Omer Yerci; Rusen Soylu; Volkan Tümay; Gülaydan Filiz; Abdullah Zorluoglu
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

Review 5.  Intussusception and leiomyosarcoma of the gastrointestinal tract in a pediatric patient. Case report and review of the literature.

Authors:  G T Furuta; D A Bross; D Doody; R E Kleinman
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

6.  Primary gastrointestinal sarcomas: analysis of prognostic variables.

Authors:  K C Conlon; E S Casper; M F Brennan
Journal:  Ann Surg Oncol       Date:  1995-01       Impact factor: 5.344

7.  Partial resection of the second portion of the duodenum for gastrointestinal stromal tumor after effective transarterial embolization.

Authors:  Naoto Kurihara; Kiyoshi Kikuchi; Minoru Tanabe; Yusuke Kumamoto; Akira Tsuyuki; Yasuo Fujishiro; Yoshihide Otani; Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima
Journal:  Int J Clin Oncol       Date:  2005-12       Impact factor: 3.850

8.  A pooled analysis of risk factors of surgically treated leiomyosarcoma of the colon in adults.

Authors:  Yun Wang; Hao Wang; Zhi-Lu Yuan; Jing-Fei Zhao; Dian-Bo Dong; Qian Gao
Journal:  World J Surg Oncol       Date:  2020-03-28       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.